Location: Home > Pharma China Web Edition
  • search
  • go
    • Other News
    Upcoming Event: 2nd Annual Biosimilars Summit 11/19/2015
    Event: 2nd Annual Biosimilars Summit
    Dates: February 8 – 9, 2016
    Venue: TBD, Berlin, Germany
    Contact: Maia Pedro
    Tel: +49 (30) 31879578
     
    The Vonlanthen Group are pleased to invite you to the "2nd Annual Biosimilars Summit" scheduled for the 8th and 9th of February, 2016 in Berlin. This innovative B2B event will enable the participants to learn about the latest trends of the Biosimilars, commercialization aspects, Regulatory advises and strategies for Biosimilars development. As biosimilars are now being developed and manufactured using todays state of the art technology and techniques, they can potentially also offer some benefits, in addition to cost, over the reference biologics. It is proved that biosimilars could save the U.S. health system close to US$44 billion in the next ten years.
     
    Key Practical Learning Points of the Summit:
    •  The latest trends of the Biosimilars
    •  Successful Commercialization of Biosimilars in Europe and USA
    •  Biosimilars In Emerging Markets – Regulatory and Commercial Considerations
    •  Industry Partnerships: Key Success Factor to Win in Biosimilar Space
    •  Regulatory Advice on Designing Biosimilar Trials
    •  Totality of Evidence and What It Means to Clinician
    •  Experience of Global Clinical Biosimilar Trials
    •  Strategies and competing products for a successful commercialization
    Relate News
    4/12/2024
  • Whooping Cough Resurges in Post-Pandemic China
    • 12/26/2023
  • China Issues Guidance Policy for High-Quality Development of Disease Prevention and Control
    • 9/15/2023
  • JW Therapeutics and 2Seventy Bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunot...
    • 8/30/2023
  • Upcoming Event: 2023 Pharma CI USA Conference & Exhibition
    • more
  • Site map | Contact Us | Links
  • © Wicon International Group